Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Domenico Penna"'
Autor:
Lucia Mangone, Domenico Penna, Francesco Marinelli, Francesca Roncaglia, Isabella Bisceglia, Francesco Merli, Alessia Ruffini, Barbara Gamberi, Alessia Tieghi, Riccardo Valli, Laura Albertazzi, Mauro Iori, Paolo Giorgi Rossi, Claudia Vener, Fortunato Morabito, Antonino Neri, Stefano Luminari
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHematological malignancies (HMs) represent a heterogeneous group of diseases with diverse etiology, pathogenesis, and prognosis. HMs’ accurate registration by Cancer Registries (CRs) is hampered by the progressive de-hospitalization of pa
Externí odkaz:
https://doaj.org/article/725ed39a764949bf8bbc7bcfc8280cec
Autor:
Ayalew Tefferi, Maura Nicolosi, Domenico Penna, Mythri Mudireddy, Natasha Szuber, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh D. Pardanani
Publikováno v:
Blood Advances, Vol 2, Iss 15, Pp 1980-1984 (2018)
Externí odkaz:
https://doaj.org/article/227de734e2e349a6acb62355f32868fa
Autor:
Domenico Penna
Publikováno v:
Medicina, Vol 57, Iss 11, p 1181 (2021)
Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis.
Externí odkaz:
https://doaj.org/article/61c8db4b2543475f9aad70a2daa5087c
Autor:
Francesco Merli, Carlo Visco, Annarita Conconi, Daniele Vallisa, Elettra Ortu La Barbera, Sara Galimberti, Roberto Mina, Marianna Sassone, Anna Guidetti, Adriano Venditti, Alessandro Corso, Francesco Marchesi, Pellegrino Musto, Agostino Tafuri, Valentina Bonuomo, Filippo Gherlinzoni, Francesco Lanza, Monia Marchetti, Safaa M. Ramadan, Marco Salvini, Massimo Massaia, Elisa Coviello, Alessandro Busca, Luigi Petrucci, Daniele Armiento, Mauro Turrini, Alessandra Romano, Chiara Cattaneo, Francesco Passamonti, Matteo G. Della Porta, Anna Candoni, Luigi Rigacci, Luca Arcaini, Livio Trentin, Valeria Cardinali, Maria Chiara Tisi, Carmine Selleri, Carlo Gambacorti-Passerini, Andrés J.M. Ferreri, Patrizia Tosi, Riccardo Bruna, Mauro Krampera, Antonio Cuneo, Nicola Stefano Fracchiolla, Daniela Cilloni, Lorenza Bertù, Paolo Corradini, Annamaria Scattolin, Roberto Cairoli, Giuseppe Visani, Domenico Penna, Marco Ladetto, Antonello Pinto, Michele Cavo, Monica Bocchia, Sofia Pilerci, Luigi Marcheselli
Publikováno v:
Blood Advances
Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c511abaff8f6767b1c8847f0db05744
http://hdl.handle.net/11568/1132840
http://hdl.handle.net/11568/1132840
Autor:
Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi, Maura Nicolosi, Naseema Gangat, Rangit Vallapureddy, Rhett P. Ketterling, Domenico Penna
Publikováno v:
Leukemia. 33:2522-2553
Autor:
Curtis A. Hanson, Ayalew Tefferi, Christy Finke, Terra L. Lasho, Domenico Penna, Animesh Pardanani, Rangit Vallapureddy, Naseema Gangat, Rhett P. Ketterling
Publikováno v:
American Journal of Hematology. 94:286-290
In the last decade, several prognostic models for primary myelofibrosis (PMF) have been introduced and shown to be effective in predicting overall survival. The main objective for this study was to identify clinical and genetic markers of very long (
Autor:
Alessandro Zerbini, Angelo Fama, Aurelio Negro, Pasquale Gianluca Giuri, Domenico Penna, Lucia Belloni
Publikováno v:
American Journal of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7183a461c8397f5e01bd9aa65e9d027
https://hdl.handle.net/11380/1258397
https://hdl.handle.net/11380/1258397
Autor:
Robin Foà, Francesco Merli, Francesco Rotondo, Domenico Penna, Francesca Re, Mariateresa Giaimo, Alessio Farcomeni, Maurizio Martelli, Arianna Di Rocco, Giulia De Luca, Luigi Petrucci, Alice Di Rocco, Antonio Cuneo, Michela Ansuinelli, Gian Matteo Rigolin
Anti-CD19 chimeric antigen receptor (CAR) T cells represent the first approved third-line therapy associated with long-term remissions in patients with refractory/relapsed (R/R) diffuse large B-cell lymphoma (DLBCL). Eligibility criteria to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6b8d2bb20f226f5f78064991c5ae75
http://hdl.handle.net/11573/1468527
http://hdl.handle.net/11573/1468527
Autor:
Ayalew Tefferi, Curtis A. Hanson, Naseema Gangat, Rangit Vallapureddy, Mythri Mudireddy, Domenico Penna, Kebede H. Begna, Christy Finke, Rhett P. Ketterling, Terra L. Lasho, Animesh Pardanani
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 9, Iss 2, Pp 1-8 (2019)
Blood Cancer Journal, Vol 9, Iss 2, Pp 1-8 (2019)
Among 1306 patients with primary myelofibrosis (PMF), we sought to identify risk factors that predicted leukemic transformation (LT) in the first 5 years of disease and also over the course of the disease. 149 (11%) LT were documented; patients who s
Autor:
Rangit Vallapureddy, Christy Finke, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi, Terra L. Lasho, Domenico Penna, Curtis A. Hanson, Rhett P. Ketterling, Natasha Szuber
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 12, Pp 1-9 (2018)
Blood Cancer Journal, Vol 8, Iss 12, Pp 1-9 (2018)